Federal regulators have signed off on a new type of flu vaccine with a booster in it, with the hope of better protecting seniors from the virus.
It’s the first flu vaccine to include what’s called an adjuvant — a compound that helps stimulate the immune system so that a vaccine is more effective.
It’s aimed at people over 65, who typically have a poor immune response to vaccines.
“Immunizing individuals in this age group is especially important because they bear the greatest burden of severe influenza disease and account…
Read the rest of the story from our partners at NBC News.
More Must-Reads From TIME
- What a Photographer Saw in the West Bank
- The Dirty Secrets of Alternative Plastics
- Accenture’s Chief AI Officer on Why This Is a Defining Moment
- We Should Get Paid for Our Online Data: Column
- Inside COP28's Big 'Experiment'
- The 100 Must-Read Books of 2023
- The Top 100 Photos of 2023
- Want Weekly Recs on What to Watch, Read, and More? Sign Up for Worth Your Time